Clinical trial Recruiting at 2 sites Interventional Ages 35 to 65 Women only

Using a new biofeedback device to help women with stress urinary incontinence

Official title: Effectiveness and Cost-effectiveness of PelviSense, a Novel Biofeedback Device With Wearable Sensors for Stress Urinary Incontinence in Women: a Randomised Controlled Trial Alongside Economic Evaluation

Run by The Hong Kong Polytechnic University · NCT05627726 · Data updated 2026-11-12

This study tests whether a new biofeedback device can help women with stress urinary incontinence improve their pelvic floor muscle training and overall symptoms compared to doing it on their own.

Quick facts

Study typeInterventional
Ages35 Years to 65 Years
SexWomen only
Enrollment142 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Drugs / interventionsradiation
Locations2 sites (Hong Kong and 1 other locations)
StatusRecruiting
StartedApril 1, 2024
Main results expectedOctober 26, 2025
Study endsOctober 26, 2026
Registry record updatedMarch 17, 2025
Trial IDNCT05627726 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are non-pregnant women aged 35 to 65 with mild to moderate stress urinary incontinence.

Probably not a fit

Patients who may not benefit include those with severe pelvic organ prolapse, severe psychological issues, or those who are postpartum within the last six months.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of the PelviSense device in assisting pelvic floor muscle training (PFMT) for women suffering from stress urinary incontinence (SUI). It compares the outcomes of women using PelviSense with those performing PFMT alone, focusing on symptom severity and cost-effectiveness. The study employs a randomized controlled trial design and includes semi-structured focus groups to gather qualitative insights from participants about their experiences. A total of 142 women aged 35 to 65 with mild to moderate SUI will be enrolled to assess the device's impact on their lives and well-being.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive and effective treatment option for women suffering from stress urinary incontinence.

How similar studies have gone: While there have been studies on various adjunctive therapies for PFMT, the PelviSense device represents a novel, non-invasive approach that has not been extensively tested in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* non-pregnant women with stress urinary incontinence (SUI),
* aged 35 to 65 years,
* women who experience mild to moderate SUI, as indicated by a pad weight gain of 1-50 g during the 1-hour pad test with stress test,
* women with a score ≥24 on the Mini-Mental State Examination.

Exclusion Criteria:

* women \<6 months postpartum,
* women with severe pelvic organ prolapse,
* women with complicated SUI due to pelvic region radiation,
* women with a body mass index (BMI) ≥30,
* women with severe psychological problems impairing study participation,
* women with mixed urinary incontinence (MUI) or urge urinary incontinence (UUI)

Where it's running

  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting
  • Kwong Wah Hospital
    Kowloon, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: PRIYA KANNAN, PhD — The Hong Kong Polytechnic University
  • Study coordinator: PRIYA KANNAN, PhD
  • Email: priya.kannan@polyu.edu.hk
  • Phone: 3400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.